Efficacy and Safety of Biologics, Allergen Immunotherapy, and Pharmacotherapies for Moderate-to-Severe Allergic Rhinitis: A Network Meta-Analysis [0.03%]
生物制剂、过敏免疫疗法和药物治疗中重度过敏性鼻炎的有效性和安全性：网状 meta 分析
Zengxiao Zhang,Dandan Fang,Chengshuo Wang et al.
Zengxiao Zhang et al.
Background: The management of moderate-to-severe allergic rhinitis (AR) is challenging given numerous advanced therapies. A comparative, evidence-based treatment hierarchy to guide the selection of biologics, allergen imm...
Medicaid Coverage and Utilization for Novel Therapies for Chronic Rhinosinusitis With Nasal Polyposis [0.03%]
有关鼻息肉慢性 rhinosinusitis 新疗法的 Medicaid 补助和使用情况研究
Eric R Ramos,Sriram Satyavolu,Ashley L Miller et al.
Eric R Ramos et al.
Most state Medicaid programs granted omalizumab (91.4%) and dupilumab (59.5%) preferred drug status. Omalizumab was the most commonly prescribed therapy among Medicaid patients between 2015 and2024. ...
The Role of Proteases in Epithelial Dysregulation in Fungal Sinusitis [0.03%]
蛋白酶在真菌性鼻窦炎上皮功能障碍中作用机制研究
Sonam Verma,Iris Lee,John S Schneider et al.
Sonam Verma et al.
Background: The role of epithelial dysregulation is poorly understood in fungal sinusitis. We aimed to examine differential gene expression and quantify protease expression in sinonasal tissue from distinct patient cohort...
Species-Level Characterization of the Nasal Microbiome in Various Disease States Utilizing Third-Generation Sequencing [0.03%]
基于第三代测序技术的健康及疾病状态下鼻腔微生物菌种水平的研究
Yasine Mirmozaffari,Cristian Roca,W Jared Martin et al.
Yasine Mirmozaffari et al.
Assessment of Lifetime Inhalational Exposure Burden and Associations With Chronic Rhinosinusitis [0.03%]
吸入暴露负担的评估及其与慢性鼻窦炎的关系研究
Nina M Westcott,Michael Ly,Anna Van Dorsten et al.
Nina M Westcott et al.
Environmental and occupational inhalational exposures are linked to chronic rhinosinusitis The Sinonasal Occupational Airborne Pollutant Exposure (SOAPE) survey assesses lifetime exposure to inhalational irritants CRS patients who underwent...
Evaluating the Role of GLP-1 Receptor Agonists in Modifying Risks of Visual and CSF Complications in Idiopathic Intracranial Hypertension [0.03%]
评估GLP-1受体激动剂在修改特发性颅内高压的视觉和脑脊液并发症风险中的作用
Amala Nayak,Aaron Tucker,Michael McWilliams et al.
Amala Nayak et al.
Local Specific IgE Levels Can Predict and Monitor the Therapeutic Response to Subcutaneous Immunotherapy With House Dust Mite [0.03%]
特异性IgE水平可预测和监测尘螨皮下免疫治疗的疗效
Xu Xu,Jingyun Li,Xu Zhang et al.
Xu Xu et al.
Background: Identifying predictive and monitoring biomarkers for allergen immunotherapy response is crucial for enhancing clinical efficacy. This study aims to investigate the systemic and local levels of immunoglobulins ...
A Novel Risk Stratification Tool for Sinonasal Inverted Papilloma Recurrence: Multi-Institutional Nomogram Incorporating Dysplasia Severity [0.03%]
一种新的鼻窦 inverted papilloma 复发风险分层工具：多机构 nomogram 包括发育不良严重程度
Tristan Tham,Peter Giannaris,Mostafa Kokabee et al.
Tristan Tham et al.
High-risk dysplasia and multifocal attachment independently predict inverted papilloma recurrence. Novel nomogram generates individualized 3-, 6-, and 9-year recurrence risk estimates. Risk-stratified surveillance may optimize postoperative...
Healthcare Utilization Among Chronic Rhinosinusitis Patients Using Glucagon-Like Peptide-1 Agonists [0.03%]
格列奈肽激动剂使用患者的慢性鼻窦炎医疗利用情况研究
Shannon S Wu,Jananee Muralidharan,Gavin Hui et al.
Shannon S Wu et al.